Tariot PN, Goldstein B, Podgorski CA, Cox C, Frambes N.
Short-term administration of selegiline for mild-to-moderate dementia of the Alzheimer's type.
Am J Geriatr Psychiatry. 1998 Spring;6(2):145-54.
PubMed.
The abstract tells us that there was no drug-plecebo difference in any outcome measure, as had been seen in an earlier study 'perhaps because the patients were studied less intensively'.
Comments
Banner Research Institute
The abstract tells us that there was no drug-plecebo difference in any outcome measure, as had been seen in an earlier study 'perhaps because the patients were studied less intensively'.
Make a Comment
To make a comment you must login or register.